1h Free Analyst Time
The renal biomarkers market is forecasted to grow by USD 1.20 billion during 2023-2028, accelerating at a CAGR of 13% during the forecast period. The report on the renal biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic kidney diseases, increase in incidence of acute kidney injury (AKI) and associated risk factors, and rapid increase in aging population.
The renal biomarkers market is segmented as below:
By End-user
- Hospitals
- Clinics and diagnostic laboratories
- Research laboratories
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the renal biomarkers market covers the following areas:
- Renal Biomarkers Market sizing
- Renal Biomarkers Market forecast
- Renal Biomarkers Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global renal biomarkers market: Abbott Laboratories, BioMerieux SA, BioPorto AS, COBO SCIENTIFIC ApS, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., IQVIA Holdings Inc., Randox Laboratories Ltd., RenalSense Ltd., Siemens AG, SphingoTec GmbH, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing awareness about kidney diseases."
According to the report, one of the major drivers for this market is the rising prevalence of chronic kidney diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- BioMerieux SA
- BioPorto AS
- COBO SCIENTIFIC ApS
- EKF Diagnostics Holdings Plc
- F. Hoffmann La Roche Ltd.
- IQVIA Holdings Inc.
- Randox Laboratories Ltd.
- RenalSense Ltd.
- Siemens AG
- SphingoTec GmbH
- Thermo Fisher Scientific Inc.
